Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jul. 01, 2012	Jul. 03, 2011
Operating activities:
Net income	$ 56,202	$ 54,674
Add: net income from discontinued operations and dispositions, net of income taxes	(558)	1,718
Net income from continuing operations	55,644	56,392
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:
Restructuring and lease charges, net	11,362	3,340
Depreciation and amortization	64,163	50,601
Stock-based compensation	10,252	7,960
Amortization of deferred debt issuance costs	1,745	1,270
Amortization of acquired inventory revaluation	4,774	378
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:
Accounts receivable, net	13,473	3,904
Inventories, net	(12,652)	(3,566)
Accounts payable	1,645	(19,838)
Excess tax benefit from exercise of equity grants	(1,139)	(8,591)
Accrued expenses and other	(56,594)	10,332
Net cash provided by operating activities of continuing operations	92,673	102,182
Net cash (used in) provided by operating activities of discontinued operations	(744)	(7,631)
Net cash provided by operating activities	91,929	94,551
Investing activities:
Capital expenditures	(11,449)	(15,970)
Changes in restricted cash balances	200	420
Payments for acquisitions and investments, net of cash and cash equivalents acquired	0	(310,351)
Net cash used in investing activities of continuing operations	(11,249)	(325,901)
Net cash provided by investing activities of discontinued operations	988	28,252
Net cash used in investing activities	(10,261)	(297,649)
Financing activities:
Payments on debt	(244,000)	(247,000)
Proceeds from borrowings	210,000	494,000
Payments of debt issuance costs	(416)	0
Payments on other credit facilities	0	(2,303)
Payments for acquisition-related contingent consideration	(9,343)	(137)
Excess tax benefit from exercise of equity grants	1,139	8,591
Proceeds from stock options exercised	11,746	23,552
Purchases of common stock	(2,063)	(109,997)
Dividends paid	(15,891)	(15,997)
Net cash (used in) provided by financing activities of continuing operations	(48,828)	150,709
Net cash used in financing activities of discontinued operations	0	(1,908)
Net cash (used in) provided by financing activities	(48,828)	148,801
Effect of exchange rate changes on cash and cash equivalents	(3,779)	29,419
Net (decrease) increase in cash and cash equivalents	29,061	(24,878)
Cash and cash equivalents at beginning of period	142,342	420,086
Cash and cash equivalents at end of period	$ 171,403	$ 395,208